NovoCure (NVCR) Operating Income (2014 - 2026)
NovoCure (NVCR) posted Operating Income of -$10.6 million for Q2 2026, up 84.33% sequentially from -$67.4 million in Q1 2026, and up 73.27% YoY from -$6.1 million in Q2 2025.
NovoCure (NVCR) Operating Income (2014 - 2026) Analysis & Trends
NovoCure has reported Operating Income for 13 years, with the latest figure at -$10.6 million in Q2 2026.
- Quarterly Operating Income rose 73.27% year-over-year to -$10.6 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$154.4 million (up 10.64% YoY) and the FY2025 annual result came in at -$153.8 million, up 9.79% from the prior year.
- Operating Income climbed to -$10.6 million in Q2 2026 per NVCR's latest filing, from -$67.4 million in the prior quarter.
- Over five years, Operating Income peaked at -$806000.0 in Q1 2022 and troughed at -$67.4 million in Q1 2026.
- A 5-year average of -$40.3 million and a median of -$40.0 million in 2025 frame the typical range for Operating Income.
- The sharpest annual moves came in 2023 and 2026: Operating Income sank 7375.06% in 2023, then jumped 73.27% in 2026.
- Over 5 years, Operating Income stood at -$43.0 million in 2022, then declined by 20.33% to -$51.7 million in 2023, then declined by 22.41% to -$63.3 million in 2024, then surged by 36.19% to -$40.4 million in 2025, then jumped by 73.85% to -$10.6 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$10.6 million, -$67.4 million, and -$40.4 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.49 Bn | 193.88 Bn | 7.27 Bn | 1.69 Bn |
| 2 | Stryker | 127.80 Bn | 124.32 Bn | 4.50 Bn | 1.66 Bn |
| 3 | Medtronic | 118.98 Bn | 109.76 Bn | 6.41 Bn | 1.87 Bn |
| 4 | Boston Scientific | 73.58 Bn | 73.04 Bn | 3.85 Bn | 1.18 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn | 513.20 Mn |
| 6 | Dexcom | 34.34 Bn | 32.39 Bn | 830.00 Mn | 318.30 Mn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.66 Bn | 2.18 Bn | 739.00 Mn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 989.17 Mn |
| 9 | Steris | 23.07 Bn | 22.59 Bn | 684.20 Mn | 285.80 Mn |
| 10 | NovoCure | 2.05 Bn | 1.61 Bn | 142.48 Mn | -10.56 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -10.56 Mn |
| Mar 31, 2026 | -67.42 Mn |
| Dec 31, 2025 | -40.39 Mn |
| Sep 30, 2025 | -36.02 Mn |
| Jun 30, 2025 | -39.52 Mn |
| Mar 31, 2025 | -37.87 Mn |
| Dec 31, 2024 | -63.30 Mn |
| Sep 30, 2024 | -32.09 Mn |
| Jun 30, 2024 | -33.58 Mn |
| Mar 31, 2024 | -41.52 Mn |
| Dec 31, 2023 | -51.72 Mn |
| Sep 30, 2023 | -58.25 Mn |
| Jun 30, 2023 | -62.66 Mn |
| Mar 31, 2023 | -60.25 Mn |
| Dec 31, 2022 | -42.98 Mn |
| Sep 30, 2022 | -24.61 Mn |
| Jun 30, 2022 | -21.13 Mn |
| Mar 31, 2022 | -806,000.00 |
| Dec 31, 2021 | -23.40 Mn |
| Sep 30, 2021 | -8.55 Mn |